CAD5.20
0.58% yesterday
Toronto, Nov 25, 10:00 pm CET
ISIN
CA94947L1022
Symbol
WELL

WELL Health Technologies Target price 2024 - Analyst rating & recommendation

WELL Health Technologies Classifications & Recommendation:

Buy
93%
Hold
7%

WELL Health Technologies Price Target

Target Price CAD7.68
Price CAD5.20
Potential
Number of Estimates 15
15 Analysts have issued a price target WELL Health Technologies 2025 . The average WELL Health Technologies target price is CAD7.68. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 14 Analysts recommend WELL Health Technologies to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the WELL Health Technologies stock has an average upside potential 2025 of . Most analysts recommend the WELL Health Technologies stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million CAD 776.05 988.81
36.35% 27.42%
EBITDA Margin 13.13% 12.88%
8.52% 1.89%
Net Margin 0.00% 4.50%
100.00%

15 Analysts have issued a sales forecast WELL Health Technologies 2024 . The average WELL Health Technologies sales estimate is

CAD989m
Unlock
. This is
3.25% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CAD991m 3.51%
Unlock
, the lowest is
CAD985m 2.85%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 CAD776m 36.35%
2024
CAD989m 27.42%
Unlock
2025
CAD1.1b 11.11%
Unlock
2026
CAD1.2b 8.41%
Unlock
2027
CAD1.3b 7.43%
Unlock
2028
CAD1.5b 13.88%
Unlock

15 Analysts have issued an WELL Health Technologies EBITDA forecast 2024. The average WELL Health Technologies EBITDA estimate is

CAD127m
Unlock
. This is
2.04% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CAD128m 2.90%
Unlock
, the lowest is
CAD126m 1.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 CAD102m 24.73%
2024
CAD127m 24.99%
Unlock
2025
CAD148m 16.18%
Unlock
2026
CAD171m 15.45%
Unlock
2027
CAD183m 7.29%
Unlock
2028
CAD221m 20.44%
Unlock

EBITDA Margin

2023 13.13% 8.52%
2024
12.88% 1.89%
Unlock
2025
13.47% 4.58%
Unlock
2026
14.34% 6.46%
Unlock
2027
14.32% 0.14%
Unlock
2028
15.15% 5.80%
Unlock

8 WELL Health Technologies Analysts have issued a net profit forecast 2024. The average WELL Health Technologies net profit estimate is

CAD44.5m
Unlock
. This is
42.33% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CAD49.8m 35.48%
Unlock
, the lowest is
CAD39.8m 48.39%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 CAD0.0 100.00%
2025
CAD17.4m 60.83%
Unlock
2026
CAD51.5m 195.18%
Unlock
2027
CAD69.7m 35.47%
Unlock
2028
CAD88.4m 26.79%
Unlock

Net Margin

2023 0.00% 100.00%
2025
1.59% 64.67%
Unlock
2026
4.32% 171.70%
Unlock
2027
5.45% 26.16%
Unlock
2028
6.06% 11.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share CAD 0.00 0.18
100.00%
P/E 29.09
EV/Sales 1.71

8 Analysts have issued a WELL Health Technologies forecast for earnings per share. The average WELL Health Technologies <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

CAD0.18
Unlock
. This is
41.94% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
CAD0.20 35.48%
Unlock
, the lowest is
CAD0.16 48.39%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 CAD0.00 100.00%
2025
CAD0.07 61.11%
Unlock
2026
CAD0.21 200.00%
Unlock
2027
CAD0.28 33.33%
Unlock
2028
CAD0.36 28.57%
Unlock

P/E ratio

Current 17.02 112.52%
2024
29.09 70.92%
Unlock
2025
74.29 155.38%
Unlock
2026
25.16 66.13%
Unlock
2027
18.57 26.19%
Unlock
2028
14.65 21.11%
Unlock

Based on analysts' sales estimates for 2024, the WELL Health Technologies stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.77 8.76%
2024
1.71 3.11%
Unlock
2025
1.54 9.99%
Unlock
2026
1.42 7.76%
Unlock
2027
1.33 6.92%
Unlock
2028
1.16 12.19%
Unlock

P/S ratio

Current 1.35 3.10%
2024
1.31 3.14%
Unlock
2025
1.18 10.00%
Unlock
2026
1.09 7.76%
Unlock
2027
1.01 6.92%
Unlock
2028
0.89 12.19%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today